Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
GANX Gain Therapeutics, Inc.	$26.1M	$0 0.0% of portfolio	0	Q3 2024 New
GLPG Galapagos Nv	$1.56B	$0 0.0% of portfolio	0	Q3 2024 New
GALT Galectin Therapeutics Inc	$72.5M	$0 0.0% of portfolio	0	Q3 2024 New
GNTA Genenta Science S.P.A.	$76.1M	$0 0.0% of portfolio	0	Q3 2024 New
GBIO Generation Bio Co.	$55.5M	$0 0.0% of portfolio	0	Q3 2024 New
GNFT Genfit S.A.	$180M	$0 0.0% of portfolio	0	Q3 2024 New
GERN Geron Corp	$1.14B	$0 0.0% of portfolio	0	Q3 2024 New
GHRS Gh Research PLC	$459M	$0 0.0% of portfolio	0	Q3 2024 New
GLYC Glycomimetics Inc	$14.2M	$0 0.0% of portfolio	0	Q3 2024 New
GOSS Gossamer Bio, Inc.	$87.4M	$0 0.0% of portfolio	0	Q3 2024 New
GRAY Graybug Vision, Inc.	$63.5M	$0 0.0% of portfolio	0	Q3 2024 New
GLSI Greenwich Life Sciences, Inc.	$161M	$0 0.0% of portfolio	0	Q3 2024 New
GRTS Gritstone Bio, Inc.	$2.19M	$0 0.0% of portfolio	0	Q3 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.25B	$0 0.0% of portfolio	0	Q3 2024 New
HCWB Hcw Biologics Inc.	$12.2M	$0 0.0% of portfolio	0	Q3 2024 New
HLVX Hille Vax, Inc.	$65.9M	$0 0.0% of portfolio	0	Q3 2024 New
IMAB I Mab	$89.7M	$0 0.0% of portfolio	0	Q3 2024 New
IDYA Ideaya Biosciences, Inc.	$1.14B	$0 0.0% of portfolio	0	Q3 2024 New
IDRA Idera Pharmaceuticals, Inc.	$188M	$0 0.0% of portfolio	0	Q3 2024 New
IGMS Igm Biosciences, Inc.	$49M	$0 0.0% of portfolio	0	Q3 2024 New
IKNA Ikena Oncology, Inc.	$53.3M	$0 0.0% of portfolio	0	Q3 2024 New
IMGO Imago Bio Sciences, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
IMRA Imara Inc.	$552M	$0 0.0% of portfolio	0	Q3 2024 New
IMTX Immatics N.V.	$427M	$0 0.0% of portfolio	0	Q3 2024 New
IMMX Immix Biopharma, Inc.	$28.5M	$0 0.0% of portfolio	0	Q3 2024 New
ICCC Immucell Corp	$40.3M	$0 0.0% of portfolio	0	Q3 2024 New
IMRX Immuneering Corp	$57.8M	$0 0.0% of portfolio	0	Q3 2024 New
IMUX Immunic, Inc.	$31.2M	$0 0.0% of portfolio	0	Q3 2024 New
IBRX Immunity Bio, Inc.	$1.27B	$0 0.0% of portfolio	0	Q3 2024 New
IMCR Immunocore Holdings PLC	$1.45B	$0 0.0% of portfolio	0	Q3 2024 New
IMNM Immunome Inc.	$121M	$0 0.0% of portfolio	0	Q3 2024 New
IPA Immuno Precise Antibodies Ltd.	$14.4M	$0 0.0% of portfolio	0	Q3 2024 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	0	Q3 2024 New
IMRN Immuron Limited	$11.8M	$0 0.0% of portfolio	-	Q3 2024 New
IMMP Immutep LTD	$170M	$0 0.0% of portfolio	0	Q3 2024 New
INAB In8 Bio, Inc.	$6.86M	$0 0.0% of portfolio	0	Q3 2024 New
INDP Indaptus Therapeutics, Inc.	$7.85M	$0 0.0% of portfolio	0	Q3 2024 New
IFRX Infla Rx N.V.	$103M	$0 0.0% of portfolio	0	Q3 2024 New
INM In Med Pharmaceuticals Inc.	$3.83M	$0 0.0% of portfolio	0	Q3 2024 New
INMB Inmune Bio, Inc.	$149M	$0 0.0% of portfolio	0	Q3 2024 New
IPHA Innate Pharma Sa	$138M	$0 0.0% of portfolio	0	Q3 2024 New
INVA Innoviva, Inc.	$1.3B	$0 0.0% of portfolio	0	Q3 2024 New
INZY Inozyme Pharma, Inc.	$57M	$0 0.0% of portfolio	0	Q3 2024 New
INSM Insmed Inc	$10.6B	$0 0.0% of portfolio	0	Q3 2024 New
IVA Inventiva S.A.	$99.9M	$0 0.0% of portfolio	0	Q3 2024 New
IOBT Io Biotech, Inc.	$27.4M	$0 0.0% of portfolio	0	Q3 2024 New
IONS Ionis Pharmaceuticals Inc	$4.93B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
IOVA Iovance Biotherapeutics, Inc.	$986M	$0 0.0% of portfolio	0	Q3 2024 New
ITOS I Teos Therapeutics, Inc.	$272M	$0 0.0% of portfolio	0	Q3 2024 New
JAGX Jaguar Health, Inc.	$103M	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.